HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warning Letter Depicts Personal-Care Regulation's Present, Possible Future

This article was originally published in The Rose Sheet

Executive Summary

Cosmetic firms already are being closely watched by FDA for overreaching product claims, but if formal good manufacturing practices are established for the sector down the road under regulatory reform legislation, companies could be targeted increasingly with warning letters like that issued to Beauty & Health International for quality-control violations at its Garden Grove, California facility.

Advertisement

Related Content

Think FDA Inspections Are Painful Now? These Could Be The Good Old Days
Aloe Farms' Claims, GMP Practices Rub FDA The Wrong Way
CIR Panel Emphasizes GMPs In Final 'Safe As Used' Ingredient Reports
What Comes First In FDA Land, Excessive Claims Finding Or Facility Inspection?
FDA Warns Gilchrist & Soames Following Massive Contamination Recall
Sen. Feinstein’s Cosmetics Safety Bill Launches With GOP Cosponsor
Supplement Industry Offers Cautionary Tale For Mandatory Cosmetic GMPs
P&G’s NIOXIN Shows How To Address Hair Loss Without An FDA Warning
FDA Warning To L’Oreal Creates Uncertainty For Anti-Redness, Dark Spot Treatments
ICCR Ushers Forth Updated Cosmetic GMP Guidelines From FDA

Topics

Advertisement
UsernamePublicRestriction

Register

RS019936

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel